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Abstract.  Human squamous carcinoma (COLO-16) 
cells release factors which specifically stimulate the 
synthesis of major acute-phase plasma proteins in hu- 
man and rodent hepatic ceils. Anion exchange, hy- 
droxyapatite, lectin, and gel chromatography of condi- 
tioned medium of COLO-16 cells result in separation 
into three distinct forms of hepatocyte-stimulating fac- 
tors (designated HSF-I, HSF-II, and HSF-III) with ap- 
parent molecular weights of 30,000,  50,000 and 
70,000,  respectively. None of the preparations con- 
tains detectable amounts of thymocyte-stimulating  ac- 
tivity. Each of the three HSF forms stimulates the 
accumulation of mRNA for al-antichymotrypsin in 
the human hepatoma cell line, HepG2. When the 
same factors were added to primary cultures of adult 
rat hepatocytes, the expression of the same set of 
plasma proteins was modulated as by nonfractionated 
medium. The hormonally induced accumulation of 
mRNA for acute phase proteins is qualitatively corn- 
parable to that occurring in the liver of inflamed rats. 
Unlike in human cells, in rat liver cells dexametha- 
sone acts additively and synergistically with HSFs. 
The only functional difference between the three HSF 
forms lies in the level of maximal stimulation. HSF-I 
represents the predominant form produced by normal 
human keratinocytes and closely resembles in molecu- 
lar size and isoelectric point the activity produced by 
activated peripheral blood monocytes while the larger 
molecular weight forms are more prevalent in human 
as well as mouse squamous carcinoma cells. The ob- 
servation that HSFs from different sources elicit essen- 
tially the same pleiotropic response in hepatic cells led 
to the hypothesis that the species-specific  reaction of 
adult liver cells to inflammatory stimuli is pre-pro- 
grammed and that the function of any HSF is to 
trigger and tune the execution of this fixed cellular 
process. 
T  H  E  regulation of plasma protein synthesis in the mam- 
malian liver during an acute systemic injury is most 
remarkable in that the expression of a subset of pro- 
teins, the acute-phase reactants, is drastically increased while 
that of others is reduced (21, 24). Surprisingly, little is known 
about  the  signals mediating this  hepatic response and the 
mechanism leading to the coordinate modulation of structur- 
ally nonrelated and genetically nonlinked proteins (7, 9). An 
essential step towards understanding of  this process is defining 
the  source and  the  structural  identity  of the  modulating 
activities (18, 33,  37,  42). The functional properties of the 
proposed factors have to entail the stimulation of the entire 
species-specific set of acute-phase plasma proteins with kinet- 
ics and magnitude of change as produced in vivo. It is there- 
fore essential to  establish whether  the  pleiotropic  hepatic 
response is controlled by one factor or by a set of specific 
factors. 
Analysis of cells involved in or affected by an acute-phase 
reaction have indicated that activated blood monocytes (31), 
tissue macrophages (34), and growing keratinocytes (38) re- 
lease factors with some of the liver-regulating  characteristics. 
In some instances, in vivo and in vitro tests have suggested a 
structural correlation of the liver-regulating factor with inter- 
leukin- 1 (IL-  1)~ ( 11, 39). However, detailed analyses of struc- 
tural properties of the activity (4, 22, 32, 43) and response of 
cultured liver cells (4, 26) have cast doubts on the absolute 
identity of IL-1 and the liver-regulating activity (for the pur- 
poses of this paper and in accordance with Ritchie and Fuller 
[32], designated hepatocyte-stimulating factor [HSF]). 
In  addition  to  producing  the  IL-l-like,  epidermal  cell- 
derived thymocyte-activating factor (ETAF), human squa- 
mous carcinoma (COLO- 16) cells  release constitutively a wide 
spectrum of structurally distinct HSFs (4). This is in contrast 
dhbreviations  u.wd in lhis paper.  ETAF, epidermal cell-derived thymocyte- 
activating factor: HSF, hepatocyte-stimulating  factor:  IL-1, interleukin I. 
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dominantly one form of HSF (32). The existence of structur- 
ally different factors provides the opportunity to address the 
questions concerning (a) the complexity of the factors needed 
to achieve a  full  hepatic acute-phase response, and  (b) the 
correlation of HSFs with IL-I/ETAF. To this end, the HSFs 
were fractionated from conditioned media of the producer 
cells and tested for their ability to modulate the synthesis of 
major acute-phase plasma proteins in human hepatoma cells 
and cultured rat hepatocytes. Although differing in physico- 
chemical  properties,  each  of the  partially purified factors, 
which were devoid of IL-1/ETAF activity, was able to stim- 
ulate qualitatively and quantitatively the synthesis of  the same 
set of plasma  proteins. This uniform response of liver cells 
and common specificity of various HSF forms may lend new 
ideas as to the  possible  mechanism  of regulation of acute- 
phase proteins. 
Materials and Methods 
Source of  HSF 
Conditioned medium from primary cultures of human epidermal cells, COLO- 
16  cells,  lipopolysaccharide-stimulated human peripheral  blood  monocytes, 
and mouse squamous carcinoma (MCA-3) cells (generously provided by Dr. 
M.  Kulez-Martin, Department of Experimental Therapeutics, Roswell  Park 
Memorial Institute) served as the source of HSFs (4). The media, collected after 
conditioning for 24 h (monocytes) or 96 h (epidermal cells), were cleared from 
suspended cells by centrifugation and were stored at -70"C until further use. 
Purification of HSF 
Separation of HSF-I. -I1, and -111, present in conditioned medium of COLO-16 
cells, has been achieved by the following  sequence of chromatographic steps: 
(a) DEAE-Sephadex (A-50,  Pharmacia Fine Chemicals, Piscataway~ N  J),  (b) 
hydroxyapatite (BDH Chemicals, Poole,  England),  (c) concanavalin A-Sepha- 
rose (Pharmacia Fine Chemicals), and (d) gel filtration  on Sephadex G-100. 
(Details are described in the legends to Figs. 2-4.) lsoelectric  focusing of HSFs 
was carried out for 60-70 KV/h at 4"C in a  110-ml sucrose gradient column 
containing 1% ampholines, pH 3.5-10 (LKB Instruments, Inc., Gaithersburg, 
MD). 
HSF activity was  monitored during purification  by two  separate assays: 
monolayers (2  cm  z) of HepG2 cells  were  treated  for 24  h  and primary rat 
hepatocytes for 48 h  with dialyzed  aliquots of fractions added to the culture 
medium which contained also 1 uM dexamethasone (4). The specific increase 
in  production  of human aJ-antichymotrypsin or rat  c~2-macroglobulin over 
basal level was quantitated by rocket  immunoelectrophoresis of aliquots of 
culture medium and expressed in nanograms secreted  per hour and  l0  s ceils 
(4). A standard of conditioned medium of COLO-16 cells, producing maximal 
response, was included in all  HSF activity assays. One unit of HSF activity is 
defined as the concentration of HSF needed to stimulate the synthesis of a~- 
antichymotrypsin  in HepG2 cells to a one-third level of  that maximally induced 
by the standard. All quantitations of human HSF activity were carried out on 
HepG2 cells because of the cells' uniform and highly reproducible responses. 
However,  the unit values obtained for identical  HSF preparations, when tested 
on both HepG2 cells and rat hepatocytes (stimulation of ~2-macroglobulin  to 
one-third maximal level), were within a range of a factor of 3 (compare Figs. 6 
and  9).  Activity of mouse-derived HSFs were  measured exclusively on  rat 
hepatocytes. IL-I  activity was determined on  mouse thymocytes using the 
standard co-stimulator assay previously described (35). 
Analysis of Cell Response to HSF 
HepG2 cells (20) and primary cultures of hepatocytes, prepared from  10-14- 
wk-old male Buffalo rats (36) and maintained as monolayer in collagen-coated 
dishes (3) served as target cells. The effect of HSF treatment on the synthesis 
of plasma proteins was determined by metabolic labeling of the cells  with 
[35S]methionine (h000 Ci/mmol,,New England Nuclear. Boston, MA) for 6 h, 
Figure  1.  Quantitation ofa~-acid glycoprotein mRNA from established rat hepatocyte cultures. Monolayers of rat hepatocytes were established 
by culturing in serum-containing medium for 20 h: then the cells were treated with medium supplemented as indicated with  100 U/ml HSF-I 
and  1 uM dexamethasone, or 80 U/ml HSF-III.  After the times indicated, total cell RNAs were extracted.  Serial dilutions of the RNAs were 
blotted into nitrocellulose and hybridized with nick-translated plasmid DNA (plRL-21) containing cDNA to a~-acid glycoprotein mRNA. To 
determine nonspecific hybridization, the same amounts of kidney  RNA were applied.  The fluorographic image of the dot blots after a  24-h 
exposure is reproduced. 
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4). Plasma proteins which do not separate well on two-dimensional polyacryl- 
amide gels, including arcysteine proteinase inhibitor, fibrinogen, and a~-acid 
glycoprotein,  were isolated by crossed immunoelectrophoresis  using monospe- 
cific, polyclonal antibodies, and nonlabeled carder proteins (3). The relative 
incorporation of isotype into the separated proteins was used as a measure for 
change in synthesis. 
To assess change in specific mRNA, total RNA was extracted from the cell 
monolayers by lysis in guanidine thiocyanate and collected  by centrifugation 
through CsCI (6). 
Hybridization Analysis of RNA 
To expand our repertoire  of specific probes to rat acute-phase plasma protein 
mRNA, we have established a cDNA library  to liver mRNA from an experi- 
mentally inflamed male rat (two successive injections of 0.5 ml turpentine, 24 
h apart).  The preparation of the library  was carded out by following exactly 
the procedure worked out and perfected  by Dr. D. Dickinson (Department of 
Molecular Biology,  Roswell  Park Memorial Institute), In short, first  strand 
eDNA was synthesized in the presence ofactinomycin D (5) followed by second 
strand synthesis by nick translation reaction (modified from 29). The eDNA 
was homopolymeric tailed  (25),  annealed to tailed pBR322~ and transfected 
inlo JW-355.  The library  (8,000  colonies) was screened  for  inflammation- 
induced sequences (14).  The nature of inserts in cloned plasmid DNA was 
determined by mRNA selection and cell-free translation (30).  Products were 
identified  on  a  two-dimensional polyacrylamide gel  by  co-migration  with 
immunoprecipitated, cell-free precursor forms (4, 8). The plasmids encoding 
the following proteins were used (in parenthesis insert size in base pairs): plRL3, 
cq-cysteine  proteinase inhibitor, identical  to aracute-phase globulin (1,600); 
plRL9, haptoglobin (1.300); plRL14, a-fibrinogen (975); plRL20, 3,-fibrinogen 
(1,650);  and plRL21, aracid glycoprotein  (850).  In addition, the following 
probes were included: p1796 (mouse arantitrypsin [15]), p1706 (mouse albu- 
min [1]) and pal76 (a2,-globulin [23]). The mRNAs for human m-antichy- 
motrypsin and apolipoprotein A-I were probed with cDNA, pHACI (15), and 
a  2.2-kb human apoA-I  gene fragment inserted in  pSV2  (19)  (generously 
provided by Dr. J. k. Breslow, The Rockefeller  University, New York),  respec- 
tively. 
To determine the relative concentration of specific mRNAs, serial dilutions 
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of cellular  RNA  were  applied  onto  nitrocellulose  and  probed  with  nick- 
translated plasmid DNA (17). Fig.  l shows a representative result of an actual 
experiment. Hybridization was quantitated by densitometry  of  the fluorographs, 
corrected for background reactions (hybridization to equal amounts of kidney 
RNA), and related  to the amount of input RNA. 
Measurements of Relative Rates of mRNA Synthesis 
To label  RNA, the culture medium was removed from rat hepatocytes (8 x 
106 cells in 75-cm  2 collagen-coated flasks) and replaced  by  Imt of the same 
medium  but  containing  1  mCi  [SH]uridine  (Amersham Corp.,  Arlington 
Heights, IL 60 Ci/mmol). The temperature of the culture was maintained at 
37"C.  After  15  min, the cells  were  washed twice  with  ice-cold  phosphate- 
buffered saline and the total cellular RNA was isolated (6). Filter hybridization 
of SH-RNA to immobilized DNA was carded out as described  by MeKnight 
and Palmiter (28) and Ucker et at. (40).  10 ~g plasmid DNA bound to 5-ram 
diameter nitrocellulose  filter disks ensured DNA excess in all hybridizations. 
Filters  carrying cDNA for different mRNAs were  combined and hybridized 
with  the individual  RNA  preparations  for  72  h.  The  bound  radioactivity 
resistant to RNase was counted twice for 50 min in a Beckman LS7000 liquid 
scintillation counter. Since a relatively low amount of tritium radioactivity  was 
recovered,  a  simultaneous measurement of hybridization efficiency  by using 
s2P-cDNA  was not done.  However,  hybridization of S2P-cRNA in separate 
reactions,  but under identical conditions, yielded efficiencies ranging between 
8 and 20% which are in conformity with earlier  reports (40). 
Results 
Separation of HSFs of COLO-16 Cells 
As reported previously (4),  conditioned medium  of COLO- 
16 cells contains HSF activity which migrates on Sephadex 
G-100  with  apparent  molecular  weights  ranging  between 
15,000 and  100,000  and with predominant  peaks at 30,000 
and 50,000 (see also Fig. 4). Chromatography of such condi- 
tioned medium  on DEAE-Sephadex  resulted in  separation 
into two HSF forms (Fig. 2). There was no significant differ- 
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Figure 2.  DEAE-Sephadex chromatography of conditioned medium of COLO- 16 cells. 400 ml of 4-d-conditioned medium of COLO- 16 cells 
was dialyzed against 10 mM Tris HCI, 25 mM NaCI, pH 8.5, and then applied to a DEAE-Sephadex column (2.6 x  35 cm) in the same buffer. 
Breakthrough was collected in 50-ml fractions. After washing the column with 2 liters of 10 mM Tris HCI, 25 mM NaCI, the bound material 
was eluted with a  NaCI gradient and collected in  15-ml fractions. Aliquots (0.5 ml) of the fractions after dialysis against phosphate-buffered 
saline were tested for HSF activity on HepG2 cells (0, al-antichymotrypsin) and on rat hepatocytes (O, armacroglobulin) and for stimulation 
of thymocyte proliferation (A). The basal level of [3H]thymidine incorporation by mitogen-stimulated thymocytes was 5,000-7,000 cpm and 
was subtracted from all measurements. The value for maximal thymocyte stimulation was 60,000-65,000 cpm. The gradient fraction  I 1-20, 
concentrated by ultrafiltration to 20 ml, was used for gel filtration (see Fig. 4). The breakthrough fractions 2-8 were pooled, adjusted to pH 
6.8, and used for hydroxyapatite chromatography (Fig. 3). 
The Journal of Cell Biology, Volume 102, 1986  372 ence in the profile of HSF activity when tested for stimulation 
of m-antichymotrypsin in HepG2 cells or aE-macroglobulin 
in rat hepatocytes. The breakthrough fractions contained a 
substantial amount of HSF but no detectable IL-1  activity. 
The presence of an IL-l inhibitor activity was ruled out by 
mixing experiments (data not shown). The major bound HSF 
activity eluted slightly ahead of the bulk proteins and sepa- 
rated clearly from the IL-1  activity. The fraction of bound 
HSF activity, but essentially free of IL-1 activity (indicated by 
bar in  Fig.  2),  has been  denoted  HSF-I and was used  for 
subsequent experiments. 
The nonbound material was further chromatographed on 
hydroxyapatite (Fig. 3). Again, a separation into two fractions 
was obtained. The bound HSF activity appeared immediately 
after applying the phosphate gradient but showed extensive 
trailing during subsequent elution.  Only the  fractions with 
the highest specific HSF activity, denoted HSF-II, were used 
for further analysis. 
Nonetheless, the nonbound fraction still showed significant 
HSF activity, and this was denoted HSF-III. This HSF form 
could be quantitatively recovered from the large breakthrough 
volume by chromatography on concanavalin A-Sepharose. 
Chromatography on Sephadex G- 100 of concentrated frac- 
tions containing HSF-I, -II, and -III  revealed that three distinct 
molecular weight forms of HSF had been recovered from the 
original conditioned medium (Fig. 4). A significant co-migra- 
tion  of IL-1  activity was not  observed.  These  HSF  forms, 
obtained from Sephadex G-100 columns (as indicated in Fig. 
4),  were then used for studying the hepatic response. When 
the same purification scheme was applied to culture medium 
that had  not been conditioned by COLO-16 cells,  no HSF 
activity was recovered. This ruled out an isolation of a  not 
previously recognized factor present in fetal calf serum. 
Five independent purifications of HSFs from conditioned 
medium of COLO-16 cells yielded the same qualitative sepa- 
ration as illustrated in the example reproduced in Figs. 2-4. 
In each case, we  found that the different HSF forms were 
present essentially in the same relative proportion and that 
the  purification  had  recovery values  comparable to  those 
shown in Table I. However, the absolute amounts of HSF 
activity actually obtained varied considerably from one prep- 
aration to the other. This variability could be mainly attrib- 
uted to the quite different concentrations of HSF activity in 
the conditioned media, ranging from 50 to 900 U/ml. Since 
all the media were collected during the same culture period 
ofCOLO- 16 cells (that is, during growth phase before reaching 
confluency), it appears that production of HSFs is dependent 
not only on growth but also on other, not yet known, cellular 
processes and/or culture conditions. The quantitation of the 
purification (Table I) indicated a major reduction of activity 
during the last chromatographic step. We found that ultrafil- 
tration of the low protein-containing samples, either before 
or after gel filtration was a major cause for loss of  both protein 
and activity. Therefore, to improve recovery of HSF activity 
intended for cell regulation studies, we added 0.1% fetal calf 
serum to the HSF fraction before the last concentrating step. 
Chromatographic Comparison of  HSFs from 
COLO-16 Cells with Those from Other Cell Types 
Having observed that COLO-16 cells release several forms of 
HSFs, the questions arose as to (a) whether nontransformed 
epidermal  cells  release  a  similar  spectrum  of  HSFs;  (b) 
whether one of the forms shares structural similarities with 
HSF of peripheral blood monocytes, and (c) whether mouse 
squamous carcinoma cells also are producers of HSFs equiv- 
alent to the human factors. 
Size  fractionation  of conditioned  medium  from  normal 
human keratinocytes revealed the presence of HSF activity 
with an apparent molecular weight of 30,000 (Fig. 5 A). When 
conditioned medium was fractionated as outlined in Figs. 2- 
4, essentially all activity showed a chromatographic behavior 
identical to HSF-I of COLO-16 cells (data not shown). Since 
previous analysis of blood monocytes also had indicated  a 
predominant form of HSF with a molecular weight of 30,000 
(4,  22,  32,  43),  we applied the same purification scheme to 
conditioned medium of these cells. The majority of the activ- 
ity could again be recovered in the same fractions as HSF-I 
from COLO-16  cells  (Fig.  5B).  Isoelectric focusing of this 
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Figure 3. Hydroxyapatite chroma- 
tography  of  HSF-II.  Nonbound 
material  of the  DEAE-Sephadex 
chromatography  (Fig.  2) was  ap- 
plied to a  hydroxyapatite column 
(1.6  x  16 cm) in  10 mM sodium 
phosphate,  pH  6.8.  The  break- 
through  material  (containing 
HSF-III) was collected as one frac- 
tion (600 ml). The HSF activity is 
indicated  by  vertical bars.  Open 
bars,  stimulation  of  a~-antichy- 
motrypsin  in  HepG2  cells. 
Hatched bars, a2-macroglobulin in 
rat  hepatocytes.  The activity was 
concentrated  by  chromatography 
on a 2-ml column of concanavalin 
A-Sepharose and eluted in  10 ml 
0.5  M  a-methylmannoside  in 
phosphate-buffered saline. The hy- 
droxyapatite column was washed 
with  1 liter of 10 mM phosphate 
buffer and then eluted with a phosphate gradient in fractions of 5 ml, The eluate was assayed as in Fig. 2. The fractions, 9-18, containing HSF- 
I1, were pooled and concentrated to 10 ml by ultrafiltration. 
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Figure 4.  Gel chromatography of COLO-16-derived HSFs. 2 ml of 
10-fold-concentrated  conditioned  medium  of  COLO-16  cells 
(TOTAL) or 2  ml  of the concentrated fractions containing HSF-1 
(DEAE-bound, Fig. 2), HSF-IL (hydroxyapatite bound, Fig. 3), and 
HSF-II1 (hydroxapatite breakthrough and concanavalin A  bound, 
Fig. 3) were chromatographed against the gravity on a column of 
Sephadex  G-100 (1.6  ×  100 cm) in phosphate-buffered  saline. The 
eluate was collected in 3-ml fractions and assayed as in Fig. 2. Bars 
indicate the pooled fraction  used for further studies. No absorbance 
at 280 nm could be detected in the eluate from the chromatography 
of HSF-II and -III. In the top panel, the elution position of molecular 
weight marker proteins are indicated (values in thousands). 
peak yields a single band of activity with an apparent isoelec- 
tric point (pl) of 5.5. A minor portion of the total HSF activity 
produced by human monocytes chromatographed like HSF- 
II  of COLO-16  cells.  Due  to  the  low  amount  of activity 
available, no determination of pI values could be done yet. 
The mouse squamous carcinoma cell line MCA-3 also was 
found to produce HSF activity. However, the relative amount 
of activity released by  these  cells was  much  less  than  by 
COLO-16 cells. To obtain a maximal response of rat hepato- 
cytes (HepG2 cells did not respond to the mouse factor; see 
Table L  Purification  of HSFs 
Fraction  Protein  HSF activity  Specific  activity 
mg  U  U/mg protein 
Conditioned medium of  2,800  320,000  114 
COLO-16 
DEAE-Sephadex  bound  88  50,000  568 
DEAE-Sephadex  break-  2.8  48,000  17,100 
through 
Hydroxyapatite bound  0.3  12,400  41,300 
Hydroxyapatite break-  0.2  14.000  70,000 
through 
Sephadex G-100 
HSF-I  0.076  12,000  156,000 
HSF-II  0.011  1.200  109,000 
HSF-III  0.005  1,800  360,000 
Conditioned medium of COLO-16 cells  (400 ml of the same preparation  as in 
Fig. 2) was fractionated  as illustrated  in Figs.  2-4. with the modifications  that 
the fractions  eluted from DEAE-Sephadex,  hydroxyapatite,  and coneanavalin 
A (HSF-I.  -II, and -111, respectively)  were  concentrated  to 3 ml by ultrafiltration 
and that the entire samples  were chromatographed  on Sephadex  G-100. Total 
protein amount and  HSF activity were determined in the pooled fraction 
obtained from the indicated  chromatographic  step. 
also reference 4), conditioned medium of 10-20 times greater 
concentration than COLO-16 medium had to be used. Frac- 
tionation of MCA-3 medium on Sephadex G-100 resulted in 
separation  into  two  major  peaks  with  apparent  molecular 
weights of 50,000  and 70,000  (Fig. 5C).  The  50,000-mol-wt 
component could be purified like HSF-II from COLO-16 cells 
(data not shown). This HSF form was at least as effective as 
the human HSF-II in stimulating the synthesis of major acute- 
phase proteins in rat hepatocytes (see Table III below). DEAE 
chromatography of MCA-3 medium also indicated the pres- 
ence of activity that binds to the anion exchanger. Whether 
this portion represents an  HSF form  comparable in charge 
and size with HSF-I remains to be shown. At present, we do 
not  have  any  indication as to  the  similarity of the  higher 
molecular weight form (>50,000) with HSF-III. 
Properties of the HSFs Purified from COLO-16 Cells 
The three HSF forms separated from conditioned medium of 
COLO- 16 cells do not only differ in size when analyzed to gel 
filtration but  also  in  isoelectric points  (Table  II).  HSF-III, 
unlike HSF-1 and -It, failed to focus into discrete bands and 
appears quite uniformly spread over a  pH  range from  5  to 
7.5.  Determination of the pI of active HSF was additionally 
complicated by the fact that the activity of all forms was acid 
labile. Treatment  of the  HSF preparations with  buffers  of 
different pH indicated a gradual loss of activity when the pH 
dropped below 6. Exposure of HSFs to pH 5.0 for 12 h at 4°C 
resulted in a 90% reduction of the activity (data not shown). 
A  major  structural  distinction between  the  HSFs is that 
HSF-II and -II1 bind to concanavalin A while HSF-I does not 
show  any  detectable  affinity.  Although  the  lectin  binding 
suggested the presence of carbohydrate residues, their actual 
existence still has to be verified by biochemical analysis. More 
detailed presentation of the biochemical properties and  the 
structural relatednesss of the different HSF forms will be the 
subject of a future study. 
The  separation  of HSF  activities into  three  structurally 
distinct forms and simultaneous removal of thymocyte-stim- 
ulating activity is, however, sufficient to address the question 
concerning the qualitative and quantitative effect of distinct 
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Figure 5.  Gel  filtration  of HSFs  from  different cell  sources.  3-d- 
conditioned medium of normal human keratinocytes  (A) and mouse 
squamous carcinoma (MCA-3) cells (C) were concentrated 10-fold 
by ultrafiltration. Aliquots of 2 ml were separated on a Sephadex G- 
100 column as in Fig. 4.  In B,  30 ml of conditioned medium of 
human blood monocytes activated by S. aureus toxin A (4, 35) was 
chromatographed first on a DEAE-Sephadex column (similar to Fig. 
2) and the bound fraction, after concentrating  to 2 ml, was separated 
on Sephadex G-100. The HSF activity in the eluate of each column 
was determined only on rat hepatocytes, since HSF of MCA-3 cells 
failed to significantly stimulate HepG2 cells. 
Table II.  Properties of  HSFs from COLO-16 Cells 
Maximal stimulation 
Molecular  lsoelectric  Con A  HepG2  Rat hepato- 
Form  weight  point  binding  cells  cytes 
HSF-I  30,000  5.5  - 
HSF-II  50,000  7.2 and  + 
8.5-9.0 
HSF-III  70,000  ?  + 
%  % 
100  100 
50-70  100 
50  50 
HSF preparation on the liver response.  Specifically, we asked 
whether all three HSF forms have the same biological activity, 
meaning the ability to induce all the changes in plasma protein 
expression  associated  with  acute-phase reaction, or whether 
each  form  influences only a  part  of the  hepatic  response. 
Therefore, we first defined basic properties of the regulatory 
activities by analyzing the effects of HSFs on mRNA concen- 
tration and cellular production of a~-antichymotrypsin in the 
phenotypically stable  HepG2 cells. Since the acute-phase re- 
sponse of nontransformed liver  cells  encompasses a  wider 
spectrum of modulated plasma proteins than exists in HepG2 
cells, we extended our characterization of HSF activities  to 
the regulation  of all  major acute-phase plasma proteins  in 
adult rat hepatocytes. Analyzing the effect of human factors 
on rat cells also allowed  us to determne to what degree  the 
species-specific liver response is dependent upon the inducing 
agent. 
Response of Human Hepatoma Cells to HSFs 
When serial dilutions of HSF-I, -II, and -III were  tested  for 
their effect on a~-antichymotrypsin synthesis in HepG2 cells, 
we observed that, at submaximal HSF concentrations, a sim- 
ilar  relationship existed  between the cell response and HSF 
concentration (Fig. 6). The factors differed, however,  in their 
maximal level of stimulation. The results  from five prepara- 
tions consistently showed that (a) HSF-I was most effective 
and  could  modulate  the  synthesis  at  least  to  the  level  of 
nonfractionated conditioned medium; (b) the maximal stim- 
ulation by HSF-II ranged between 50 and 70%; and (c) the 
activity of HSF-III was always limited to 50% maximal stim- 
ulation.  Combination of maximal amounts of HSF-III and 
HSF-II did  not  result  in  a  response  that  surpassed  that  of 
HSFolI alone. Likewise, addition of a maximal concentration 
of HSF-III to a submaximal concentration of HSF-I did not 
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Figure 6.  Activity of HSFs from COLO-16 cells. Fractions from G- 
100 columns containing HSF-I, -II, and -II1 (Fig. 4) were concentrated 
by ultrafiltration to 2  ml and added to 4  ml of Dulbecco's modified 
Eagle's medium containing 10%  fetal calf serum (equal dilution  1). 
Serial dilutions of these preparations were tested for their ability to 
stimulate the synthesis of at-antichymotrypsin in HepG2 cells. The 
means of duplicate cultures are shown. The maximal level reached 
by nonfractionated conditioned medium of COLO-16 cells (COLO- 
16 CM) was defined as 100% (Table 11). 
375  Baumann et al. Regulation of  Acute-phase Reactants lead  to  an  enhancement  of the  HSF-I  response  (data  not 
shown). 
The difference in the ability of the various HSF forms, in 
particular HSF-III, to induce the a]-antichymotrypsin neces- 
sitated a modification of the definition of HSF activity units 
introduced  by  Ritchie  and  Fuller  (31)  which  is based  on 
titration  of HSF  preparation  to  the  level  of half-maximal 
stimulation  of acute-phase  protein  synthesis.  To  have  an 
estimate for the activity of all HSF forms but without intro- 
ducing separate unit definitions for each HSF form, we chose 
as a unit of HSF activity the concentration of HSF needed to 
stimulate the synthesis of a~-antichymotrypsin in HepG2 cells 
to  33%  maximal level.  The  100%  level was defined as the 
level reached maximally by nonfractionated conditioned me- 
dium  of COLO-16  cells.  By  measuring the  effect of HSFs 
from human monocytes and COLO-16 cells on a~-antichy- 
motrypsin synthesis in HepG2 cells and on fibrinogen synthe- 
sis in rat hepatocytes (using the same assay system as Ritchie 
and Fuller  [31]),  we could calculate that about four of our 
HSF units equal one HSF unit of Ritchie and Fuller. 
The  stimulation  of a~-antichymotrypsin production  is  a 
consequence  of an  increase  in  functional  mRNA  (4),  As 
depicted in Fig. 7, the HSF-mediated accumulation of mRNA 
is rapid and attains its maximal level within 12 h. There is no 
significant difference in the time course of the response to the 
three HSF forms. In each case, the relative change of mRNA 
concentration achieved within 24 h is comparable to that of 
cellular synthesis of a]-antichymotrypsin (Figs. 6 and 7). The 
response  is  gene  specific and  is  not  a  result  of a  general 
increase of mRNA for secretory proteins as illustrated by the 
nonaffected  or  even  slightly  reduced  level  of mRNA  for 
apolipoprotein A- l. The apparent absence of a lag period in 
induction of ai-antichymotrypsin mRNA suggested that the 
cellular reaction triggered by HSF might influence directly 
the ai-antichymotrypsin gene expression and not be depend- 
ent on generating an intermediary regulatory protein (2, 41). 
This notion  is supported by the  observation that the HSF- 
stimulated  mRNA  accumulation  is  not  at  all  affected  in 
HepG2 cells whose protein de novo synthesis has been com- 
pletely inhibited by cycloheximide during the HSF treatment 
(Fig.  8 shows the  results with HSF-I; the same results were 
obtained when HSF-II and -III were used). Furthermore, HSF 
had no detectable influence on the relative amounts or basal 
level  of  a]-antichymotrypsin  mRNA  in  actinomycin  D- 
treated cells, suggesting that HSF does not exercise a signifi- 
cant  change  in  posttranscriptional  stability  of the  cellular 
mRNA for this protein. 
Although glucocorticoids were found to have stimulatory 
effects on the expression of several acute-phase proteins in 
rodent  liver cells,  including  the  mouse and  rat at-antichy- 
motrypsin homologs (2, 3, 9, 22), there is no discernible effect 
of dexamethasone on the HSF action and on the stimulation 
and stability of cytoplasmic mRNA for a]-antichymotrypsin 
in HepG2 ceils (Fig. 8). This apparent lack of a requirement 
of glucocorticoids for HSF activity in HepG2 cells is in sharp 
contrast to HSF-regulated plasma proteins in rat hepatocytes. 
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Figure  7.  Time course of mRNA induction by HSF in HepG2 cells.  Monolayers of HepG2 cells were treated with medium containing HSF-I 
(100 U/ml), HSF-II (100 U/ml), or HSF-III (10 U/ml). Cellular RNA were extracted at the time indicated. The concentration of mRNAs for 
~rantichymotrypsin (open symbols) and apolipoprotein A-1 (apo A-l, closed symbols) were measured by dot blot hybridization. The values 
obtained from three separate experiments are expressed as the relative increase above or decrease below the level of the mRNAs in cells not 
treated with HSFs. 
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Figure 8.  The effect of inhibitors of protein and RNA synthesis on 
stimulation of a~-antichymotrypsin mRNA in HepG2 cells.  Mona- 
layers of HepG2  cells in  25-cm  2 flasks  were cultured for  18  h  in 
medium alone, in medium containing either 1 pM dexamethasone, 
100  U/ml HSF-I, or a  combination of dexamethasone and HSF-I. 
One set of cultures were kept free of inhibitor (Control), one was pre- 
treated  for 2  h  and  then  maintained in  the presence of 5  pg/ml 
cycloheximide,  and another set was similarly pre-treated and main- 
tained in the presence of 5 gg/ml actinomycin  D. The concentration 
ofinhibitors  was sufficient  to reduce protein and RNA synthesis  more 
than 95%.  Total cellular RNA were extracted after the treatments. 
Cycloheximide treatment lowered the yield of RNA per monolayer 
by 20-25%  and actinomycin by  35-45%  when compared to cells 
maintained in the absence of inhibitors. Relative concentration of 
mRNA for ~t-antichymotrypsin and apolipoprotein A-1 were quan- 
titated by dot blot hybridization. The means of duplicate cultures 
were related to nontreated control cells. 
Response of Rat Hepatocytes to HSFs 
IfHSFs actually represent the universal inducers of  the hepatic 
acute-phase reaction (32),  the  definition  of their biological 
activity should  include  the stimulation  of the  entire set of 
acute-phase reactants. Since none of the available hepatoma 
cell lines show regulated expression of more than a few acute 
phase plasma proteins, we had to resort to primary culture of 
adult hepatocytes. Although the differentiated phenotype of 
cultured rat hepatocytes is not optimally preserved in tissue 
culture (12,  16), these cells have still proven to be one of the 
best in vitro systems in that they react to inflammatory stimuli 
by increased synthesis of almost all major acute-phase plasma 
proteins (4,  22,  31-34).  Rat liver cells are unique  in that a 
full response is dependent on glucocorticoid (4).  Therefore, 
to properly assess the activities of HSF-I, -II or -III, we had to 
determine separately the contribution of  the steroid, the HSFs, 
and the combination of the two, to the regulated expression 
of each acute-phase plasma protein. In most cases, however, 
it was sufficient to quantitate the HSF activity by determining 
the  factors  specific  effect  on  the  expression  of individual 
plasma proteins in dexamethasone-treated cells (3, 4, 22, 31- 
34,  43).  Nevertheless, one  has to keep in  mind that  dexa- 
methasone treatment alone is able to stimulate the production 
of several  plasma  proteins  above  the  level  of nontreated 
control cells (2-4,  12). 
When we tested in rat hepatocytes the activity of HSF-I, 
-II, or -III to stimulate the cellular production of the marker 
acute-phase  reactants  a~-acid  glycoprotein,  fibrinogen,  and 
a2-macroglobulin, above the level established by dexametha- 
sane, we obtained essentially identical concentration-depend- 
ent responses for each protein (Fig. 9). The relative effective- 
ness of the HSF forms was very comparable to that deter- 
mined in HepG2 cells (Fig.  6). The only difference was that 
in rat hepatocytes, HSF-II was equally effective as HSF-I or 
nonfractionated conditioned medium. 
To assess  the  specific influence  of the  HSFs  on a  wider 
spectrum of plasma proteins and to determine in each case 
the contribution of dexamethasone to the overall regulation, 
we measured the relative change in cellular synthesis of major 
acute-phase proteins (Table III, representative of three inde- 
pendent experiments). Surprisingly, HSF-I, -II, and -III stim- 
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Figure  9.  HSF concentration-dependent  response of rat hepatocytes. 
Cultures of rat hepatocytes from one preparation were treated for 48 
h with the same media and corresponding  dilutions as used on HepG2 
cells in Fig. 6.  l pM dexamethasone was added to each culture. The 
rate of synthesis of fibrinogen, a,-acid glycoprotein, and c¢2-macro- 
globulin  was  determined  by  rocket  immunoelectrophoresis. The 
means of duplicate cultures are reproduced. 
377  Baumann et al. Regulation of  Acute-phase Reactants Table  IlL  Effect of  HSFs on the Relative Synthesis of Plasma Proteins in Cultured Rat Hepatocytes 
Relative incorporation  (x 10  4) 
Incorporation  arcysteine  Haptoglobin 
into total me-  a2-macro-  arantichy-  aracid gly-  proteinase  (prohaptoglobin) 
Treatment  dium protein  globulin  motrypsin  coprotein  inhibitor  + B-haptoglobin  Fibrinogen  Hemopexin  Albumin 
cpm/ug total 
cell protein 
0 h control  7,150  <1  64  5  17  162  174  52  911 
48 h control  5,070  <1  24  7  4  82  62  102  824 
Dex  6,660  42  122  61  22  131  151  78  1,030 
CM COLO  5,570  < 1  296  34  15  140  206  91  620 
CM COLO + Dex  9,200  259  871  209  116  285  601  200  603 
HSF-I  4,950  <1  152  42  12  133  183  110  599 
HSF-I + Dex  8,400  268  484  186  97  312  544  198  779 
HSF-11  5,390  < 1  260  39  20  150  220  104  618 
HSF-11 + Dex  10,130  300  1,065  201  105  304  512  217  744 
HSF-III  5,100  <1  57  22  10  95  120  87  660 
HSF-III + Dex  7,180  101  408  115  63  224  305  180  693 
HSF-II ofMCA-3 +  10,870  435  910  227  119  331  670  207  630 
Dex 
Duplicate  monolayers  of rat  hepatocytes  in  24-well dishes were treated  for 48  h  with  culture  medium alone  (control);  medium  containing  nonfractionated 
conditioned  medium of COLO-16 cells (150 U/ml (CM COLO); same plus 1 t~M dexamethasone; HSF-I, -II, or -III (100 U/ml each) plus 1 uM dexamethasone: 
and HSF-II isolated from conditioned  medium of MCA-3 ceils (100 U/ml) plus dexamethasone. After labeling of the cells with [sSS]methionine  (100 uCi/ml) for 6 
h, the radioactivity incorporated  into total medium protein was measured. 50 ~1 of labeled culture medium from each well was separated by two-dimensional gel 
electrophoresis or by crossed  immunoelectrophoresis  (a~-acid glycoprotein,  a~-cysteine proteinase  inhibitor  and  fibrinogen). The  radioactivity  present  in the 
indicated plasma proteins was measured and related to the total amount of radioactivity used for analysis. The values represent means of the duplicate cultures. 
ulated  the  synthesis  of the  same  set  of major  acute-phase 
plasma proteins including all rat-specific ones, while albumin 
was  decreased.  The  qualitative  effect  was  not  significantly 
different  from  that  described  for  nonfractionated  medium 
(see  also  reference  4).  Although  each  HSF  response  had  a 
similar glucocorticoid requirement, the magnitude of overall 
change was dependent upon the type of HSF used.  Hepato- 
cytes exposed to maximal concentrations of HSF-III displayed 
only one-half stimulation of all major acute-phase proteins as 
compared  to  those treated  with  HSF-I or -II. The  relative 
proportion of the changes elicited by each HSF is, however, 
similar.  The  uniformity  of the  hepatic  response  was  also 
apparent when the hepatocytes were treated with mouse HSF 
(e.g., HSF-II of MCA-3 cells,  Table III). 
By  comparing the  regulation  of individual  proteins,  re- 
markable  differences  in  the  response  to  HSF  alone,  dexa- 
methasone alone, and a combination of both, became appar- 
ent. Two extreme examples are found in (a) a2-macroglobu- 
lin,  whose synthesis was not inducible  by HSFs alone,  but 
was primarily  stimulated  by HSF in  the  presence  of dexa- 
methasone; and (b) a~-acid glycoprotein whose synthesis was 
similarly stimulated by both hormones. In general, however, 
the synergistic action of dexamethasone and HSFs prevailed. 
Furthermore, the presence of dexamethasone was even essen- 
tial for maintenance of basal level expression of several pro- 
teins, e.g., a~-antichymotrypsin, fibrinogen, and haptoglobin. 
The broad effect of each HSF form was not only manifested 
at the level of protein synthesis but also at the level of mRNA 
(e.g., Fig. 1). The similarity of action is already detected when 
the time course of mRNA accumulation was measured (Fig. 
10,  shown  for HSF-I; essentially the  same  results  were ob- 
tained with  HSF-II and HSF-III). In these experiments,  the 
hepatocytes were cultured for the first 20 h in serum-contain- 
ing medium  but  without additional  hormones.  During this 
period the cells established their typical cell morphology and 
membrane organization (36) and recovered their responsive- 
ness to HSFs. The responsiveness to dexamethasone, however, 
was never impaired as a consequence of cell preparation (data 
not shown). After this cellular adaptation period, the hormone 
treatments were started.  By choosing this regimen, we could 
unambiguously assess  the  regulatory influence  of HSF and 
dexamethasone  on  the  basal  expression  of plasma  protein 
mRNAs of receptive cells.  As is apparent from Fig.  10, the 
accumulation  of mRNA  for different  acute-phase  proteins 
followed an identical time course, suggesting that hormonal 
treatment controls each mRNA species by a similar or even 
common mechanism.  The kinetics differed,  however,  from 
that of ~-antichymotrypsin mRNA in HepG2 cells (Fig.  7) 
by an initial lag period. This difference in the response seems 
to be more general to rat hepatocytes since a lag period was 
observed regardless of whether the cells were treated with HSF 
or dexamethasone alone (Fig.  10 shows the example of ~t o 
acid glycoprotein). Although conditions as well as hormonal 
environments are not comparable, the time course of accu- 
mulation for the same mRNAs in vivo during an inflamma- 
tion is surprisingly similar. A major distinction lies, however, 
in the magnitude of change induced. 
To complete the characterization of the biological activities 
of HSFs,  we determined  to what degree the  HSF-mediated 
regulation of mRNA for the major acute-phase plasma pro- 
teins compares to that occurring during inflammation in vivo. 
This analysis was important for assessing not only the activity 
of the HSFs but also the reproducibility of a  hepatic acute- 
phase response in cultured rat hepatocytes. For this purpose, 
monolayers of hepatocytes were established and then treated 
for 24  h  with  HSF-I or -II, with  dexamethasone,  and with 
combinations of the HSFs and dexamethasone (HSF-III was 
omitted  due  to  its  lower  induction  level).  The  changes  in 
relative  amount  of mRNA  for several  acute-phase  plasma 
proteins  and  control  proteins  were  quantitated  before  and 
after the treatments (Table IV). 
When the amount  of mRNA in the control cultures was 
related  to that  present  at  0  h,  an  interesting  phenomenon 
became apparent.  During the first 20 h, a substantial portion 
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Figure 10.  Time  course  of mRNA  induction in  rat  hepatocytes. 
Monolayers of  rat hepatocytes were established in 75-cm  2 flasks. After 
20 h in culture,  treatments  of duplicate  monolayers were started (0 
h). The media contained either HSF-I (100 U/ml), 1 pM dexameth- 
asone, or both. After various times, total cellular RNA was extracted 
and  measured  for the  relative  change  of mRNA for the  plasma 
proteins indicated. Only in the case of a~-acid glycoprotein, the results 
obtained  with all treatments  are reproduced;  in all other cases, the 
presentation  of data are limited to HSF-I plus dexamethasone.  The 
top panel shows the time course of mRNA accumulation  after an in 
vivo inflammation  (0-200 scale applies to a,-acid glycoprotein). 
of the mRNA for several plasma proteins was lost, a finding 
that  has also been  reported  elsewhere  (16).  This decline  in 
some, but not all, instances is reflected in a reduced synthesis 
and  secretion  of the  proteins  (Table  III and  reference  4). 
Treatment of the hepatocytes with HSFs and dexamethasone- 
induced changes in the amount of mRNA for major acute- 
phase plasma proteins which closely correlate with the changes 
in protein synthesis (Table III). This strongly suggests that the 
HSF-modulated protein production is mainly regulated at the 
mRNA level.  A  remarkable  exception  is  albumin,  where  a 
several-fold decrease of mRNA does not manifest in a similar 
reduction in  protein  synthesis (compare Tables III and  IV; 
see also reference 4). 
The response of cultured hepatocytes, although being very 
specific, is quantitatively less than that observed in liver (Fig. 
10 and Table IV). The maximal concentrations of mRNAs 
attained by in vitro treatments were without exception below 
those in  vivo. The most striking example is mRNA for a~- 
cysteine proteinase inhibitor, which in vivo is one of the most 
prominent acute-phase reactants but whose in vitro regulation 
is the least reproducible (4, 22). If, however, the initial loss of 
RNA  as  well  as  the  gradual  deterioration  of the  hepatic 
phenotype are taken  into consideration,  the  magnitudes  of 
HSF-mediated  mRNA  accumulation  are  quite  substantial 
and, as in the case of a~-acid glycoprotein, even close to that 
observed in vivo. Contrary to the rapid loss of a2,-mRNA in 
vivo, the concentration of this mRNA is maintained constant 
in tissue culture. It shows even less variation than a,-antitryp- 
sin mRNA whose expression is known to be not significantly 
affected by inflammation in vivo (Table IV). 
HSFs induce in vitro not only quantitative, but also quali- 
tative changes in mRNA species which are characteristic for 
acute-phase reaction of the rat liver. As indicated in Table III, 
rat  hepatocytes,  like  HepG2  cells,  synthesize  increased 
amounts  of al-antichymotrypsin  after  HSF-treatment.  We 
have noted that in vivo inflammation stimulated the synthesis 
of a~-antichymotrypsin by the liver cells and that this change 
was the consequence of a  specific alteration  in the  mRNA 
population  (Fig.  11A).  Using  as  a  hybridization  probe  a 
cDNA for mouse contrapsin, the structural homolog to hu- 
man  at-antichymotrypsin (15),  we detected that during the 
course of inflammation the predominant mRNA form of 2 
kb, which is present in normal rat liver, was reduced and that 
two additional forms of 2.2 and 5.5 kb were increased. This 
shift in hybridizable mRNA was independent of corticoste- 
roids  since  liver  of adrenalectomized  rat  showed the  same 
inflammation response. However, the in vivo treatment with 
dexamethasone  was  able  to  mimic  a  part  of that  mRNA 
modulation; that is, to increase the amount of large size forms 
without affecting the basal level of the 2-kb forms. Sequence 
analysis of cDNAs corresponding to the  different  forms of 
mRNA have indicated that the polymorphism in mRNA is 
not the result of modification in processing of a single form 
of transcript; rather, the mRNA actually encodes homologous 
but  nevertheless  structurally  different  proteins  (Hill,  R.  E., 
manuscript  in  preparation).  Surprisingly,  the  change in  a~- 
antichymotrypsin mRNA forms was not manifested  in  the 
appearance of structurally distinguishable  proteins (4).  HSF 
treatment  of hepatocytes  in  culture  was  able  to  induce  a 
similar inflammation-specific alteration in al-antichymotryp- 
sin  mRNAs.  Although  the  magnitude  of change  was  less 
prominent  in vitro, a  proper modulation was still  apparent 
(Fig.  1 ! B, representative for three independent HSF-I treat- 
ments; HSF-II showed the same result).  During the culture 
period of 48 h in normal medium, the 2-kb mRNA form was 
generally reduced. The presence of dexamethasone alone pre- 
vented the loss of this form and stimulated the appearance of 
the 2.2-kb form. HSF-I alone was able to elevate slightly the 
amount  of the  2.2-kb  form but  in combination with  dexa- 
methasone, this form became predominant.  Under this con- 
dition even a low amount of the 5.5-kb form was discernible. 
So  far  we  have  presented  evidence  that  HSFs  regulate 
protein synthesis (Table III) by increased mRNA accumula- 
379  Baumann et al. Regulation of  Acute-phase Reactants Table IV.  Modulation of mRNA for Acute-phase Plasma Protein in Established Monolayers of  Rat Hepatocytes 
Relative change in mRNA 
aracid glyco-  at-cysteine pro- 
Treatment  protein  tease inhibitor  Haptoglobin  a-fibrinogen  3,-fibrinogen  Albumin  a~-antitrypsin  a2u-globulin 
20 h  0/+0.5  -0.5/0  -1/-0.5  -2/-3  -1/-1  -2/-3  0/-0.5  0/-0.5 
44 h control  0/+3  -0.5/-0.5  -2/-1  -3/-3  -0.5/0  -3/-3  0/-0.5  -0.5/-0.5 
Dex  +6/+17  +0.5/+0.5  -0.5/0  0/0  +0.5/+1  -2/-2  0/0  -0.5/0 
HSF-I  +1/+7  +1/+1  0/0  0/+0.5  0/0  -3/-4  0/-0.5  -0.5/0 
HSF-I + Dex  +115/+56  +19/+8  +3.5/+2  +3/+3  +3/+2.5  -3/-3  0/+0.5  -0.5/0 
HSF-II  +4/+3  + 1.5/+ 1  +0.5/0  +0.5/+0.5  +0.5/0  -3/-3.5  0/0  -0.5/-0.5 
HSF-II + Dex  +89/+41  +9/+7  +3/+1.5  +2.5/+3  +2.5/+2  -3/-3  0/+0.5  0/0 
CM COLO + Den  +76/+49  +14/+9  +4/+2  +4/+3  +3/+3  -3.5/-3.5  +0.5/+0.5  -0.5/0 
24 h inflamed in vivo  +213/+121  +42/+26  +4/+14  +25/+12  +12/+8  -5/-4  +0.5/+0.5  -4/-2 
Rat hepatocytes in 75-cm  2 flasks were first cultured for 20 h  in serum-containing medium withou)t  any further addition of factors. The monolayers were then 
incubated for an additional 24 h in fresh medium alone (control), medium with 1 M dexamethasone (Dex), with 100 U/ml HSF-I,  100 U/ml HSF-II, and with a 
combination of dexmethasone and HSFs.  Total cellular RNAs were prepared at 0, 20, and 44 h, and quantitated by dot blot hybridization for the presence of 
mRNA for the plasma proteins indicated. The values of two independent experiments represent the factor by which the mRNA amount has increased above (+) 
or decreased below (-) the level of mRNA at 0  h. Changes ranging between -0.5  and +0.5 were considered to be not significant and are indicated by "0". To 
compare with in vivo conditions, the changes in the mRNA observed in liver 24 h after a turpentine-induced inflammation are included. 
tion (Table IV). That this HSF effect is also manifested at the 
level of mRNA synthesis, we could demonstrate only for a~- 
acid glycoprotein mRNA (Table  V,  experiments  limited  to 
HSF-I). Relative rates of mRNA synthesis were determined 
by metabolic pulse labeling of hepatocytes followed by quan- 
titation of the radioactive mRNA by filter hybridization. To 
evaluate adequately the  hormone action,  we also measured 
synthesis  rates  in  cells  immediately  after  preparation  (0  h 
control) and in cells not treated with hormones (24 h control). 
To illustrate the validity of the method and specificity of the 
regulation, we included a2u-globulin mRNA into our analysis 
because of this RNA's high abundance and stable concentra- 
tion which are not affected by hormone treatment. Although 
quite  variable  from  one  experiment  to another,  the results 
presented  in  Table  V  indicate  that  HSF-I  alone  had  no 
apparent  influence  on the  relative  synthesis  rate  of aL-acid 
glycoprotein mRNA, but could enhance significantly the syn- 
thesis in cells treated with  dexamethasone.  Hence,  only the 
specific increase mediated by HSF in dexamethasone-treated 
cells  appears  to  be  a  useful  measure  for HSF  activity  on 
transcription.  A  surprising finding was that rat hepatocytes, 
unlike  rat  hepatoma  cells  (41),  respond  to  dexamethasone 
alone by a several-fold increased relative synthesis of a~-acid 
glycoprotein mRNA. 
The hormone-induced changes in mRNA synthesis corre- 
late qualitatively well with  changes in  RNA concentrations 
(Table IV), suggesting that the regulated expression of al-acid 
glycoprotein is at least in part the consequence of increased 
gene transcription.  Unfortunately, measurements of mRNA 
for haptoglobin  and  a~-cysteine proteinase  inhibitor  in  the 
same cells did not show any significant deviations from basal 
values  (data  not  shown).  These  results  are  not  unexpected 
considering the low magnitude of mRNA stimulation (Table 
IV). 
All of the above presented data confirm that different HSF 
forms of human cells can  each modulate the expression  of 
the  same  set  of major  acute-phase  plasma  proteins  in  rat 
hepatocytes.  The  regulation  is  manifested  at  the  level  of 
mRNA concentration which resembles qualitatively  and to 
some extent quantitatively the response of liver cells to acute 
inflammation in vivo. The human HSFs can act on hepatic 
Table V.  Effect  of HSF on Relative Synthesis Rates of 
a~-Acid Glycoprotein mRNA 
Relative rate of 
cpm Hybridized  synthesis (ppm) 
glob-  glob- 
RNAsample  Input  pBR322  AGP  ulin  AGP  ulin 
cpm 
(x 1o  -~) 
Experiment I 
0 h control  6.0  6  47  411  7  68 
24 h control  1.0  2  8  34  6  32 
Dexamethasone  1.3  2  70  41  56  31 
HSF-I  0.8  2  10  30  10  35 
HSF-I + Dex  1.5  3  326  63  215  40 
Experiment II 
0 h control  4.3  4  5  202  <1  46 
24 h control  0.9  1  5  29  4  31 
Dexamethasone  1.5  2  41  34  26  21 
HSF-I  1.7  6  22  63  9  34 
HSF-I + Dex  1.1  3  69  30  60  25 
In two separate experiments, monolayers of rat hepatocytes were established in 
75-cm  2 flasks. After a 20-h culture in medium with 10% fetal calf serum alone, 
the cells were treated for 4 h with fresh culture medium (control), with medium 
containing either l  taM dexamethasone, 100 U/ml HSF-I, or  l taM dexameth- 
asone plus 100 U/ml HSF-I. The cells immediately after adhering to the plates 
(0 h) or after treatment (24 h) were labeled with [3H]uridine, The cellular RNA 
was extracted, hybridized to immobilized pBR322 DNA alone and with cDNA 
to ~racid glycoprotein (AGP),  and a2u-globulin. The actual amounts of filter- 
bound radioactivity measured as well as calculated as fraction of the total input 
radioactivity (in part per million) are reproduced. 
cells  of different  species;  the  response  of the  liver  cells  is, 
however, strictly species specific. 
Discussion 
The presented  purification  scheme provided us with  prepa- 
rations of structurally distinct HSFs which, although not being 
pure,  allowed  us to address the questions concerning com- 
plexity of liver-regulating factors, spectrum of biological activ- 
ity, and the relationship to thymocyte-stimulating factor, in 
particular IL-1. Previous studies have already indicated that 
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encoding  c~j-antichymotrypsin in 
rat liver cells. (Top)  Effect of in 
vivo treatments.  Aliquots of total 
liver RNA (25 ug) were separated 
on  a  1.5% agarose gel  in  2.2% 
formaldehyde, transferred to nitro- 
cellulose, and probed  with  nick- 
translated  plasmid  DNA  (p54) 
containing cDNA-to-mouse  con- 
trapsin, the structural homolog to 
human a~-antichymotrypsin (15). 
The lanes contain liver RNA from 
a nontreated  male rat (1), a male 
rat after 4 h (2), 12 h (3), 24 h (4), 
or 48 h (5) turpentine-induced  in- 
flammation, a rat  14 d after adre- 
nalectomy (6), a similar adrenal- 
eetomized rat but 24 h after tur- 
pentine injection (7) or 24 h after 
dexamethasone injection (8), and 
a normal rat treated for 4 h (9), or 
24  h  (10)  with  dexamethasone. 
(Bottom)  Effect of in vitro treat- 
ments. Hepatocytes were placed in 
culture,  and after  20  h  the  cells 
were treated  for  additional  24  h 
with  medium alone,  or  medium 
containing  either 1 uM dexameth- 
asone, 100 U/ml HSF-I, or a com- 
bination of the two. Total cellular 
RNA was analyzed as in top panel. 
The lanes contain RNA extracted 
from cells 1 h (1) and 20 h (2) after 
placing in culture, and from cells 
after treatment with medium alone 
(3), or medium with dexametha- 
sone  (4), HSF-I  (5), and  HSF-I 
plus dexamethasone (6). For com- 
parison, RNA from a normal rat 
(7) and 24-h inflamed rat (8) were 
included. The numbers at the left 
indicate the positions of the ribo- 
somal  RNAs  and  represent  the 
sizes in kilobases. 
HSFs exist with apparent molecular weights greater than that 
of IL-I  (4,  22,  32).  We have now achieved the isolation of 
HSFs from COLO-16 cells that are essentially free of thymo- 
cyte-stimulating activity. The thymocyte stimulation assays 
were carried out with concentrations of HSF preparations up 
to  10 times higher than that needed to reach maximal stim- 
ulation of rat hepatocytes. Whether at even higher concentra- 
tions a  thymocyte stimulation would become apparent has 
not been tested and is also not considered to be significant. 
Although  our  results  indicate that  there  are  indeed  HSFs 
without thymocyte-stimulating activity, we cannot rule out 
the possibility that IL- 1 or IL- l-like factors also contain HSF 
activity. Functional analysis of homogeneous preparations of 
IL- 1, which are underway in several laboratories (10, 13), will 
clarify this point. 
The functional definition of HSFs should not be limited to 
the  regulation of a  single acute-phase  protein  (9,  27)  but 
should include the regulation of the entire set of acute-phase 
reactants (4, 22). Since only primary cultures of adult rodent 
hepatocytes  allow  an  experimental  assessment  of the  full 
spectrum of HSF functions, the limitation of culture systems 
has to be taken into account in the interpretation of data. As 
indicated in Tables III and IV, HSFs can specifically modulate 
the expression of acute-phase proteins. However, the quanti- 
tative effect on individual sequences differs remarkably from 
that of liver cells treated in vivo. At present, it is not known 
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reactions in vitro by HSF is due to (a) the lack of additional, 
not yet recognized factors; (b) the instability of the cellular 
phenotype; or (c) a combination of the two. Considering the 
fact that different human and murine HSF preparations can 
elicit the same response pattern in rat hepatocytes, we tend to 
believe that the isolated HSF would be sufficient in properly 
modulating most,  if not  all,  acute-phase  proteins,  but  that 
processes such as reorganization of cell morphology, re-estab- 
lishment of the cell domains, recovery of HSF responsiveness, 
and metabolic adjustment to the culture environment does 
influence and modify the execution of the HSF signal. 
Despite the drawbacks of the culture systems, the experi- 
ments  with  hepatocytes yielded an  interesting  feature.  The 
cells'  response  to  different  forms  of HSFs  is  remarkably 
uniform  and  is  strictly  rat  specific (e.g.,  stimulation  of a2- 
macroglobulin and at-cysteine proteinase inhibitor). We spec- 
ulate that the adult hepatocytes are programmed to respond 
to  inflammatory stimuli  by a  change in  the  synthesis  of a 
fixed set of plasma proteins. The function of HSFs appears to 
be to trigger and tune the execution of this program. 
To achieve a maximal response of rat hepatocytes to HSFs, 
the cells have to be cultured in the presence ofdexamethasone. 
Although not yet supported by sufficient experimental  evi- 
dence, we suspect that the role of glucocorticoids is to main- 
tain  the  cells'  sensitivity  to  HSF  either  by stimulating  the 
synthesis, or by preventing the loss of cell elements which are 
involved in mediating the HSF signal. An additional role of 
dexamethasone  is,  of course,  the  direct  influence  on  the 
expression of specific acute-phase protein genes, such as a2- 
rnacroglobulin and  al-acid glycoprotein (Tables IV and  V). 
HepG2 cells seem to differ from rat hepatocytes in that these 
cells  normally contain the  postulated  elements  in  amounts 
not limiting maximal HSF response. This would explain the 
glucocorticoid-independent HSF action (Fig.  8) and instant 
inducibility  of  a)-antichymotrypsin  mRNA  accumulation 
(Fig. 7) in these cells. 
HSF-I, -II, and -III show a  remarkable difference in their 
effectiveness (Figs. 6 and 9). Our current and limited knowl- 
edge does not provide an explanation for this distinction. Two 
alternative  possibilities  could  be  envisioned.  (a)  The  three 
HSF forms interact with the same receptors on the surface of 
the liver cells but possess different stimulating activities,  or 
(b) each HSF has a  specific receptor,  whereby the  number 
and/or activity of this receptor determined the maximal cell 
response. 
The modulation of acute-phase plasma proteins by HSFs is 
correlated  with  a  change  in  mRNA  concentration.  At the 
present, we do not know the exact molecular basis for stim- 
ulated  mRNA  expression.  The  only  indication  that  HSF 
influences transcriptional activity stems from the results with 
c~-acid  glycoprotein mRNA  in  rat  hepatocytes (Table  V). 
Moreover, the phenotypic instability of cultured rat hepato- 
cytes and present experimental limitations did not yet allow 
an  accurate  assessment  as to what  extent  a  modulation  of 
mRNA processing and turnover properties contribute to the 
acute-phase protein expression. That the latter processes can 
play an important role in regulation  of acute-phase protein 
mRNA has been recently demonstrated by Vannice et al. (41) 
for dexamethasone  induction  of al-acid glycoprotein in  rat 
hepatoma cells. 
The results of  this work have indicated two future directions 
of these studies. One direction is toward the characterization 
of the HSFs. A purification scheme has to be developed, using 
either biochemical or immunological means, which will allow 
the isolation of HSFs in pure form and in quantity sufficient 
to perform  structural  analyses.  It will  be  of importance  to 
establish whether HSF-I, -II, and -III are structurally related. 
Once purified HSF is available, identification of the hepatic 
receptors also will become feasible. 
The second direction of our future studies will address the 
cellular mechanism by which  HSF achieves the pleiotropic 
response  of liver cells.  It will  be  essential  to elucidate  the 
extent  to which changes in  transcription,  RNA processing, 
translation,  cellular  processing,  and  secretion  contribute  to 
the  regulated  expression  of diverse  plasma  proteins,  all  of 
which constitute the hepatic acute-phase reaction. 
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